Cargando…

The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients

(1) Background: Multiple myeloma is a rare cancer that primarily affects the bone marrow. Osteoclasts are responsible for increased bone resorption and, therefore, bone destruction. Bisphosphonates are a class of drugs that can slow down bone resorption by reducing the number and action of osteoclas...

Descripción completa

Detalles Bibliográficos
Autores principales: Bacci, Christian, Cerrato, Alessia, Dotto, Virginia, Zambello, Renato, Barilà, Gregorio, Liço, Albana, Semenzato, Gianpietro, Stellini, Edoardo, Zanette, Gastone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908966/
https://www.ncbi.nlm.nih.gov/pubmed/33498207
http://dx.doi.org/10.3390/dj9020011
_version_ 1783655827478937600
author Bacci, Christian
Cerrato, Alessia
Dotto, Virginia
Zambello, Renato
Barilà, Gregorio
Liço, Albana
Semenzato, Gianpietro
Stellini, Edoardo
Zanette, Gastone
author_facet Bacci, Christian
Cerrato, Alessia
Dotto, Virginia
Zambello, Renato
Barilà, Gregorio
Liço, Albana
Semenzato, Gianpietro
Stellini, Edoardo
Zanette, Gastone
author_sort Bacci, Christian
collection PubMed
description (1) Background: Multiple myeloma is a rare cancer that primarily affects the bone marrow. Osteoclasts are responsible for increased bone resorption and, therefore, bone destruction. Bisphosphonates are a class of drugs that can slow down bone resorption by reducing the number and action of osteoclasts. Intravenous injections of bisphosphonates (generally Zoledronic Acid) are administered to patients affected by Multiple Myeloma, but BRONJ is described as a serious side effect. This 5-year retrospective study aims to evaluate the efficacy of appropriate dental treatment protocols prior to initiating bisphosphonate therapy to prevent the development of BRONJ. (2) Methods: A total of 99 patients with symptomatic multiple myeloma were involved in this study (41–90 years, mean age 65 years, standard deviation 5 years). The data relating to the visits were tracked using a specific server and consulting the clinical reports. The AAOMS (American Association of Oral and Maxillofacial Surgeons) position was applied for both diagnosis and treatment. A total of 79 patients were examined before the administration of bisphosphonates (group A) and 20 after (group B). (3) Results: The entire sample required dental treatment: 23.2% underwent restorative therapy, 8% endodontic treatments, 44.4% tooth extractions. Periodontal disease was present in 41.4% of the patients. No osteonecrosis was observed in the first group, whereas BRONJ was found in five patients of the second one (25%) and two patients (10%) showed osteosclerotic areas under investigation [OR 0.026 (CI 0.0027 to 0.2454)]. (4) Conclusions: In the literature, there are no precise data about the prevalence of BRONJ. Despite the limitation of the present study, we point out that dental treatment before the treatment with intravenous bisphosphonates can help in reducing the incidence of BRONJ and good dental status is necessary for BRONJ prevention.
format Online
Article
Text
id pubmed-7908966
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79089662021-02-27 The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients Bacci, Christian Cerrato, Alessia Dotto, Virginia Zambello, Renato Barilà, Gregorio Liço, Albana Semenzato, Gianpietro Stellini, Edoardo Zanette, Gastone Dent J (Basel) Article (1) Background: Multiple myeloma is a rare cancer that primarily affects the bone marrow. Osteoclasts are responsible for increased bone resorption and, therefore, bone destruction. Bisphosphonates are a class of drugs that can slow down bone resorption by reducing the number and action of osteoclasts. Intravenous injections of bisphosphonates (generally Zoledronic Acid) are administered to patients affected by Multiple Myeloma, but BRONJ is described as a serious side effect. This 5-year retrospective study aims to evaluate the efficacy of appropriate dental treatment protocols prior to initiating bisphosphonate therapy to prevent the development of BRONJ. (2) Methods: A total of 99 patients with symptomatic multiple myeloma were involved in this study (41–90 years, mean age 65 years, standard deviation 5 years). The data relating to the visits were tracked using a specific server and consulting the clinical reports. The AAOMS (American Association of Oral and Maxillofacial Surgeons) position was applied for both diagnosis and treatment. A total of 79 patients were examined before the administration of bisphosphonates (group A) and 20 after (group B). (3) Results: The entire sample required dental treatment: 23.2% underwent restorative therapy, 8% endodontic treatments, 44.4% tooth extractions. Periodontal disease was present in 41.4% of the patients. No osteonecrosis was observed in the first group, whereas BRONJ was found in five patients of the second one (25%) and two patients (10%) showed osteosclerotic areas under investigation [OR 0.026 (CI 0.0027 to 0.2454)]. (4) Conclusions: In the literature, there are no precise data about the prevalence of BRONJ. Despite the limitation of the present study, we point out that dental treatment before the treatment with intravenous bisphosphonates can help in reducing the incidence of BRONJ and good dental status is necessary for BRONJ prevention. MDPI 2021-01-20 /pmc/articles/PMC7908966/ /pubmed/33498207 http://dx.doi.org/10.3390/dj9020011 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bacci, Christian
Cerrato, Alessia
Dotto, Virginia
Zambello, Renato
Barilà, Gregorio
Liço, Albana
Semenzato, Gianpietro
Stellini, Edoardo
Zanette, Gastone
The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients
title The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients
title_full The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients
title_fullStr The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients
title_full_unstemmed The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients
title_short The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients
title_sort importance of alliance between hematologists and dentists: a retrospective study on the development of bisphosphonates osteonecrosis of the jaws (bronj) in multiple myeloma patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908966/
https://www.ncbi.nlm.nih.gov/pubmed/33498207
http://dx.doi.org/10.3390/dj9020011
work_keys_str_mv AT baccichristian theimportanceofalliancebetweenhematologistsanddentistsaretrospectivestudyonthedevelopmentofbisphosphonatesosteonecrosisofthejawsbronjinmultiplemyelomapatients
AT cerratoalessia theimportanceofalliancebetweenhematologistsanddentistsaretrospectivestudyonthedevelopmentofbisphosphonatesosteonecrosisofthejawsbronjinmultiplemyelomapatients
AT dottovirginia theimportanceofalliancebetweenhematologistsanddentistsaretrospectivestudyonthedevelopmentofbisphosphonatesosteonecrosisofthejawsbronjinmultiplemyelomapatients
AT zambellorenato theimportanceofalliancebetweenhematologistsanddentistsaretrospectivestudyonthedevelopmentofbisphosphonatesosteonecrosisofthejawsbronjinmultiplemyelomapatients
AT barilagregorio theimportanceofalliancebetweenhematologistsanddentistsaretrospectivestudyonthedevelopmentofbisphosphonatesosteonecrosisofthejawsbronjinmultiplemyelomapatients
AT licoalbana theimportanceofalliancebetweenhematologistsanddentistsaretrospectivestudyonthedevelopmentofbisphosphonatesosteonecrosisofthejawsbronjinmultiplemyelomapatients
AT semenzatogianpietro theimportanceofalliancebetweenhematologistsanddentistsaretrospectivestudyonthedevelopmentofbisphosphonatesosteonecrosisofthejawsbronjinmultiplemyelomapatients
AT stelliniedoardo theimportanceofalliancebetweenhematologistsanddentistsaretrospectivestudyonthedevelopmentofbisphosphonatesosteonecrosisofthejawsbronjinmultiplemyelomapatients
AT zanettegastone theimportanceofalliancebetweenhematologistsanddentistsaretrospectivestudyonthedevelopmentofbisphosphonatesosteonecrosisofthejawsbronjinmultiplemyelomapatients
AT baccichristian importanceofalliancebetweenhematologistsanddentistsaretrospectivestudyonthedevelopmentofbisphosphonatesosteonecrosisofthejawsbronjinmultiplemyelomapatients
AT cerratoalessia importanceofalliancebetweenhematologistsanddentistsaretrospectivestudyonthedevelopmentofbisphosphonatesosteonecrosisofthejawsbronjinmultiplemyelomapatients
AT dottovirginia importanceofalliancebetweenhematologistsanddentistsaretrospectivestudyonthedevelopmentofbisphosphonatesosteonecrosisofthejawsbronjinmultiplemyelomapatients
AT zambellorenato importanceofalliancebetweenhematologistsanddentistsaretrospectivestudyonthedevelopmentofbisphosphonatesosteonecrosisofthejawsbronjinmultiplemyelomapatients
AT barilagregorio importanceofalliancebetweenhematologistsanddentistsaretrospectivestudyonthedevelopmentofbisphosphonatesosteonecrosisofthejawsbronjinmultiplemyelomapatients
AT licoalbana importanceofalliancebetweenhematologistsanddentistsaretrospectivestudyonthedevelopmentofbisphosphonatesosteonecrosisofthejawsbronjinmultiplemyelomapatients
AT semenzatogianpietro importanceofalliancebetweenhematologistsanddentistsaretrospectivestudyonthedevelopmentofbisphosphonatesosteonecrosisofthejawsbronjinmultiplemyelomapatients
AT stelliniedoardo importanceofalliancebetweenhematologistsanddentistsaretrospectivestudyonthedevelopmentofbisphosphonatesosteonecrosisofthejawsbronjinmultiplemyelomapatients
AT zanettegastone importanceofalliancebetweenhematologistsanddentistsaretrospectivestudyonthedevelopmentofbisphosphonatesosteonecrosisofthejawsbronjinmultiplemyelomapatients